The Annual Cost of Defecation Disorders

Published Online: Tuesday, July 10, 2012
Follow Pharmacy_Times:
Fecal incontinence—the inability to control the passage of stool— is an expensive problem that can cost more than $4000 per person per year, according to a new study published in Diseases of the Colon & Rectum. The prevalence of fecal incontinence is expected to increase substantially as the elderly population continues to grow rapidly.

Investigators, led by senior author Dee E. Fenner, MD, Harold A. Furlong Professor of Women’s Health and codirector of the Michigan Bowel Control Program, calculated the hidden cost of complex defecation disorders. They examined 3 categories of expenses: direct medical cost (diagnosis, treatment and management of the condition), direct nonmedical cost (costs of nonmedical resources like protective products or transportation to care), and indirect cost, measured by loss of productivity.

Dr. Fenner concluded that because of its social stigma, too little attention is devoted to the treatment and prevention of fecal incontinence. In fact, this is the first US-based study to determine the condition’s per-patient cost.

“The disease is prevalent among men and women, and this study shows the cost is a significant burden to patients and to society,” she said.

To read more articles in this watch, click:
Flying Increases Risk of IBD Flares
T
he Annual Cost of Defecation Disorders


Related Articles
Patients inaccurately diagnosed by their health care providers are more likely to receive inappropriate antibiotics that can lead to drug resistance, clinical failure, and adverse events.
Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, details some lesser known facts about some allergic rhinitis treatments.
Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, describes the general treatment approach for allergic rhinitis.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the importance of individualizing treatment for COPD.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$